Wei Li Zhao (Weili Zhao, Wei-Li Zhao, Wei Qin)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 40

Top Topics

Histone Deacetylase

Hepatitis B Virus

Diffuse Large B Cell Lymphoma

Positron Emission Tomography

Top Venues

Clinical and translational medicine

Signal transduction and targeted therapy

British journal of haematology

Cancer communications (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Jie Xiong, Shu Cheng, Xiao Gao, Shan-He Yu, Yu-Ting Dai, Xin-Yun Huang, Hui-Juan Zhong, Chao-Fu Wang, Hong-Mei Yi, Hao Zhang, Wei-Guo Cao, Rong Li, Wei Tang, Yan Zhao, Peng-Peng Xu, Li Wang, Wei Li Zhao
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma. Signal transduction and targeted therapy 9 (1) (2024)
Yi-Ge Shen, Meng-Meng Ji, Hong-Mei Yi, Rong Shen, Di Fu, Shu Cheng, Chuan-Xin Huang, Li Wang, Peng-Peng Xu, Hong-Jing Dou, Wei Li Zhao
CD47 overexpression is related to tumour-associated macrophage infiltration and diffuse large B-cell lymphoma progression. Clinical and translational medicine 14 (1) (2024)
Jie Xiong, Shu Cheng, Xiao Gao, Shan-He Yu, Yu-Ting Dai, Xin-Yun Huang, Hui-Juan Zhong, Chao-Fu Wang, Hong-Mei Yi, Hao Zhang, Wei-Guo Cao, Rong Li, Wei Tang, Yan Zhao, Peng-Peng Xu, Li Wang, Wei Li Zhao
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma. Signal transduction and targeted therapy 9 (1) (2024)
Jie Xiong, Shu Cheng, Xiao Gao, Shan-He Yu, Yu-Ting Dai, Xin-Yun Huang, Hui-Juan Zhong, Chao-Fu Wang, Hong-Mei Yi, Hao Zhang, Wei-Guo Cao, Rong Li, Wei Tang, Yan Zhao, Peng-Peng Xu, Li Wang, Wei Li Zhao
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma. Signal transduction and targeted therapy 9 (1) (2024)
Maurizio Martelli, Luca Ceriani, Giovannino Ciccone, Umberto Ricardi, Iryna Kriachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Sara Veronica Usai, Vittorio Ruggero Zilioli, Elsa Pennese, Luca Arcaini, Anna Dabrowska-Iwanicka, Andrés José Maria Ferreri, Francesco Merli, Wei Li Zhao, Luigi Rigacci, Claudia Cellini, David C Hodgson, Codruta Ionescu, Carla Minoia, Elisa Lucchini, Michele Spina, Alexander Fosså, Andrea Janikova, Kate Cwynarski, N George Mikhaeel, Mats Jerkeman, Alice Di Rocco, Yana Stepanishyna, Umberto Vitolo, Armando Santoro, Alessandro Re, Benedetta Puccini, Jacopo Olivieri, Luigi Petrucci, Sally F Barrington, Bogdan Malkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Jan Walewski, Marek Trněný, Franco Cavalli, Mary Gospodarowicz, Peter W M Johnson, Andrew John Davies, Emanuele Zucca, null null
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yue Wang, Qing Shi, Zi-Yang Shi, Shuang Tian, Muchen Zhang, Rong Shen, Di Fu, Lei Dong, Hongmei Yi, Binshen Ouyang, Rongji Mu, Shu Cheng, Li Wang, Pengpeng Xu, Wei Li Zhao
Biological signatures of International Prognostic Index in diffuse large B-cell lymphoma. Blood advances (2024)
Yue Wang, Qing Shi, Zi-Yang Shi, Shuang Tian, Mu-Chen Zhang, Rong Shen, Di Fu, Lei Dong, Hong-Mei Yi, Bin-Shen Ouyang, Rong-Ji Mu, Shu Cheng, Li Wang, Peng-Peng Xu, Wei Li Zhao
Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma. Blood advances 8 (7) (2024)
Peipei Yang, Mingci Cai, Yang Cao, Shuang Fan, Wei Tang, Mengmeng Ji, Liang Huang, Fengrong Wang, Wei Li Zhao, Ting Niu, Xiao-Dong Mo
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis. British journal of haematology 204 (4) (2024)
Peipei Yang, Mingci Cai, Yang Cao, Shuang Fan, Wei Tang, Mengmeng Ji, Liang Huang, Fengrong Wang, Wei Li Zhao, Ting Niu, Xiao-Dong Mo
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis. British journal of haematology (2024)
Yi-Ge Shen, Meng-Meng Ji, Hong-Mei Yi, Rong Shen, Di Fu, Shu Cheng, Chuan-Xin Huang, Li Wang, Peng-Peng Xu, Hong-Jing Dou, Wei Li Zhao
CD47 overexpression is related to tumour-associated macrophage infiltration and diffuse large B-cell lymphoma progression. Clinical and translational medicine 14 (1) (2024)
Jie Xiong, Shu Cheng, Xiao Gao, Shan-He Yu, Yu-Ting Dai, Xin-Yun Huang, Hui-Juan Zhong, Chao-Fu Wang, Hong-Mei Yi, Hao Zhang, Wei-Guo Cao, Rong Li, Wei Tang, Yan Zhao, Peng-Peng Xu, Li Wang, Wei Li Zhao
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma. Signal transduction and targeted therapy 9 (1) (2024)
Zi-Xun Yan, Yan Dong, Niu Qiao, Yi-Lun Zhang, Wen Wu, Yue Zhu, Li Wang, Shu Cheng, Peng-Peng Xu, Zi-Song Zhou, Ling-Shuang Sheng, Wei Li Zhao
Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma. Nature communications 15 (1) (2024)
Peipei Yang, Mingci Cai, Yang Cao, Shuang Fan, Wei Tang, Mengmeng Ji, Liang Huang, Fengrong Wang, Wei Li Zhao, Ting Niu, Xiao-Dong Mo
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis. British journal of haematology 204 (4) (2024)
Peipei Yang, Mingci Cai, Yang Cao, Shuang Fan, Wei Tang, Mengmeng Ji, Liang Huang, Fengrong Wang, Wei Li Zhao, Ting Niu, Xiao-Dong Mo
Up-front autologous stem cell transplant in peripheral T-cell lymphoma patients achieving complete response after first-line treatment: A multicentre real-world analysis. British journal of haematology 204 (4) (2024)
Zi-Xun Yan, Yan Dong, Niu Qiao, Yi-Lun Zhang, Wen Wu, Yue Zhu, Li Wang, Shu Cheng, Peng-Peng Xu, Zi-Song Zhou, Ling-Shuang Sheng, Wei Li Zhao
Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma. Nature communications 15 (1) (2024)
Yue Wang, Qing Shi, Zi-Yang Shi, Shuang Tian, Mu-Chen Zhang, Rong Shen, Di Fu, Lei Dong, Hong-Mei Yi, Bin-Shen Ouyang, Rong-Ji Mu, Shu Cheng, Li Wang, Peng-Peng Xu, Wei Li Zhao
Biological signatures of the International Prognostic Index in diffuse large B-cell lymphoma. Blood advances 8 (7) (2024)
Maurizio Martelli, Luca Ceriani, Giovannino Ciccone, Umberto Ricardi, Iryna Kriachok, Barbara Botto, Monica Balzarotti, Alessandra Tucci, Sara Veronica Usai, Vittorio Ruggero Zilioli, Elsa Pennese, Luca Arcaini, Anna Dabrowska-Iwanicka, Andrés José Maria Ferreri, Francesco Merli, Wei Li Zhao, Luigi Rigacci, Claudia Cellini, David C Hodgson, Codruta Ionescu, Carla Minoia, Elisa Lucchini, Michele Spina, Alexander Fosså, Andrea Janikova, Kate Cwynarski, N George Mikhaeel, Mats Jerkeman, Alice Di Rocco, Yana Stepanishyna, Umberto Vitolo, Armando Santoro, Alessandro Re, Benedetta Puccini, Jacopo Olivieri, Luigi Petrucci, Sally F Barrington, Bogdan Malkowski, Ur Metser, Annibale Versari, Stephane Chauvie, Jan Walewski, Marek Trněný, Franco Cavalli, Mary Gospodarowicz, Peter W M Johnson, Andrew John Davies, Emanuele Zucca, null null
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yi-Ge Shen, Meng-Meng Ji, Hong-Mei Yi, Rong Shen, Di Fu, Shu Cheng, Chuan-Xin Huang, Li Wang, Peng-Peng Xu, Hong-Jing Dou, Wei Li Zhao
CD47 overexpression is related to tumour-associated macrophage infiltration and diffuse large B-cell lymphoma progression. Clinical and translational medicine 14 (1) (2024)
Yi-Ge Shen, Meng-Meng Ji, Hong-Mei Yi, Rong Shen, Di Fu, Shu Cheng, Chuan-Xin Huang, Li Wang, Peng-Peng Xu, Hong-Jing Dou, Wei Li Zhao
CD47 overexpression is related to tumour-associated macrophage infiltration and diffuse large B-cell lymphoma progression. Clinical and translational medicine 14 (1) (2024)
Zi-Yang Shi, Ying Fang, Peng-Peng Xu, Hong-Mei Yi, Jian-Feng Li, Yan Dong, Yue Zhu, Meng-Ke Liu, Di Fu, Shuo Wang, Qing Shi, Rong Shen, Hui-Juan Zhong, Chao-Fu Wang, Shu Cheng, Li Wang, Feng Liu, Wei Li Zhao
Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor. Clinical and translational medicine 14 (6) (2024)
Zi-Xun Yan, Yan Dong, Niu Qiao, Yi-Lun Zhang, Wen Wu, Yue Zhu, Li Wang, Shu Cheng, Peng-Peng Xu, Zi-Song Zhou, Ling-Shuang Sheng, Wei Li Zhao
Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma. Nature communications 15 (1) (2024)
Zi-Yang Shi, Ying Fang, Peng-Peng Xu, Hong-Mei Yi, Jian-Feng Li, Yan Dong, Yue Zhu, Meng-Ke Liu, Di Fu, Shuo Wang, Qing Shi, Rong Shen, Hui-Juan Zhong, Chao-Fu Wang, Shu Cheng, Li Wang, Feng Liu, Wei Li Zhao
Molecular heterogeneity of BCL2/MYC double expressor lymphoma underlies sensitivity to histone deacetylase inhibitor. Clinical and translational medicine 14 (6) (2024)
Rong Shen, Di Fu, Lei Dong, Mu-Chen Zhang, Qing Shi, Zi-Yang Shi, Shu Cheng, Li Wang, Peng-Peng Xu, Wei Li Zhao
Simplified algorithm for genetic subtyping in diffuse large B-cell lymphoma. Signal transduction and targeted therapy 8 (1) (2023)
Qing Shi, Yang He, Hong-Mei Yi, Rong-Ji Mu, Xu-Feng Jiang, Di Fu, Lei Dong, Wei Qin, Peng-Peng Xu, Shu Cheng, Qi Song, Sai-Juan Chen, Li Wang, Wei Li Zhao
Positron emission tomography-adapted therapy in low-risk diffuse large B-cell lymphoma: results of a randomized, phase III, non-inferiority trial. Cancer communications (London, England) (2023)
Ying Fang, Mu-Chen Zhang, Yang He, Chen Li, Hai Fang, Peng-Peng Xu, Shu Cheng, Yan Zhao, Yan Feng, Qian Liu, Li Wang, Wei Li Zhao
Human endogenous retroviruses as epigenetic therapeutic targets in TP53-mutated diffuse large B-cell lymphoma. Signal transduction and targeted therapy 8 (1) (2023)
Jie Xiong, Wei Li Zhao
A novel SLC1A1-RIC1 fusion sensitive to asparaginase-based therapy in natural killer/T-cell lymphoma. British journal of haematology (2023)
Wei Li Zhao, Nan Wang, Qing Shi, Rui Sun, Zhong Zheng, Di Fu, Lei Dong, Chen Li, Yifang Zhang, Pengpeng Xu, Shu Cheng, Ying Qian, Yan Feng, Li Wang, Weili Zhao
Genomic and transcriptomic characterization reveals B-cell hyperactivation and immune evasion in hepatitis B virus-associated diffuse large B-cell lymphoma. Clinical and translational medicine 13 (6) (2023)
Xiao Li, Mengke Liu, Qing Shi, Ying Fang, Di Fu, Zhi-Xiang Shen, Hongmei Yi, Li Wang, Wei Li Zhao
Elevated serum IL-13 level is associated with increased Treg cells in tumor microenvironment and disease progression of diffuse large B-cell lymphoma. Hematological oncology (2022)
Ying Fang, Mu-Chen Zhang, Peng-Peng Xu, Su-Jiang Zhang, Li Wang, Shu Cheng, Di Fu, Chun-Kang Chang, Xiao-Jian Sun, Yan Zhao, Yi-Jia Tang, Xin Tian, Hong-Mei Yi, Feng Liu, Wei Li Zhao
Integrative genome-wide chromatin accessibility and transcriptome profiling of diffuse large B-cell lymphoma. Clinical and translational medicine 12 (7) (2022)
Mu-Chen Zhang, Ying Fang, Peng-Peng Xu, Lei Dong, Rong Shen, Yao-Hui Huang, Di Fu, Zi-Xun Yan, Shu Cheng, Xu-Feng Jiang, Qi Song, Yang He, Yan Zhao, Min Lu, Jing Ye, Feng Liu, Lin Cheng, Chao-Fu Wang, Li Wang, Wei Li Zhao
Clinical efficacy and tumour microenvironment influence of decitabine plus R-CHOP in patients with newly diagnosed diffuse large B-Cell lymphoma: Phase 1/2 and biomarker study. Clinical and translational medicine 11 (12) (2022)
Yu-Jia Huo, Peng-Peng Xu, Di Fu, Hong-Mei Yi, Yao-Hui Huang, Li Wang, Nan Wang, Meng-Meng Ji, Qing-Xiao Liu, Qing Shi, Shuo Wang, Shu Cheng, Yan Feng, Wei Li Zhao
Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication. Blood cancer journal 12 (3) (2022)
Chen Xing Zhao, Jing Jing Wen, Di Fu, Peng Peng Xu, Shu Cheng, Li Wang, Chao Fu Wang, Xiao Chun Fei, Xin Wang, Jian Feng Zhou, Li Ping Su, Zhuo Wen Chen, Jie Ping Chen, Mei Yun Fang, Ting Liu, Yong Ping Song, Kang Yu, Yan Li, Jian Gu, Ming Hou, Wei Li Zhao, Jian-da Hu
Clinical and molecular features of Epstein-Barr virus-positive diffuse large B-cell lymphoma: Results in a multi-center trial. Clinical and translational medicine 11 (9) (2022)
Hao Yu, Di Fu, Peng-Peng Xu, Shu Cheng, Li Wang, Yun-Zeng Zhang, Wei Li Zhao
Implication of immune cell signature of tumor microenvironment in diffuse large B-cell lymphoma. Hematological oncology 39 (5) (2021)
Ping Zhao, Meng-Meng Ji, Ying Fang, Xiao Li, Hong-Mei Yi, Zi-Xun Yan, Shu Cheng, Peng-Peng Xu, Anne Janin, Chao-Fu Wang, Li Wang, Wei Li Zhao
A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes. Cell death & disease 12 (4) (2021)
Shuo Wang, Li Wang, Jianda Hu, Wenbin Qian, Xi Zhang, Yu Hu, Qi Zhu, Bobin Chen, Depei Wu, Chung-Chou H Chang, Pengpeng Xu, Xiaoyun Zheng, Juying Wei, Yao Liu, Guohui Cui, Yong Tang, Yan Ma, Haiwen Huang, Hongmei Yi, Wei Li Zhao
Outcomes in refractory diffuse large B-cell lymphoma: results from a multicenter real-world study in China. Cancer communications (London, England) 41 (3) (2021)
Fan Zhang, Qi-Yu Zeng, Hao Xu, Ai-Ning Xu, Dian-Jia Liu, Ning-Zhe Li, Yi Chen, Yi Jin, Chun-Hui Xu, Chang-Zhou Feng, Yuan-Liang Zhang, Dan Liu, Na Liu, Yin-Yin Xie, Shan-He Yu, Hao Yuan, Kai Xue, Jing-Yi Shi, Ting Xi Liu, Peng-Fei Xu, Wei Li Zhao, Yi Zhou, Lan Wang, Qiu-Hua Huang, Zhu Chen, Sai-Juan Chen, Xiao-Long Zhou, Xiao-Jian Sun
Selective and competitive functions of the AAR and UPR pathways in stress-induced angiogenesis. Cell discovery 7 (1) (2021)
Nan Wang, Wei Qin, Zhong Zheng, Ming Zhao, Jie Xiong, Hai Fang, Rui Sun, Yichao Wang, Chen Li, Lei Dong, Xiao-Jian Sun, Li Wang, Pengpeng Xu, Shu Cheng, Haimin Xu, Fan Zhang, Wei Li Zhao
Hepatitis B virus-associated follicular lymphoma presents T-cell inflamed phenotype and response to lenalidomide. Cancer communications (London, England) (2021)
Wei Qin, Xufeng Jiang, Jianhua You, Rui Guo, Qing Shi, Lei Dong, Rong Shen, Shu Cheng, Pengpeng Xu, Ying Qian, Biao Li, Li Wang, Wei Li Zhao
Deauville score evaluation of interim PET/CT in primary mediastinal large B-cell lymphoma. European journal of nuclear medicine and molecular imaging 48 (11) (2021)
Yiwen Cao, Peizhan Chen, Minci Cai, Qing Shi, Pengpeng Xu, Li Wang, Yang He, Hui Wang, Wei Li Zhao
Prognostic impact of B-vitamins involved in one-carbon metabolism in patients with diffuse large B-cell lymphoma. Hematological oncology 38 (4) (2020)
Rui Sun, Zhong Zheng, Li Wang, Shu Cheng, Qing Shi, Bin Qu, Di Fu, Christophe Leboeuf, Yan Zhao, Jing Ye, Anne Janin, Wei Li Zhao
A novel prognostic model based on four circulating miRNA in diffuse large B-cell lymphoma: implications for the roles of MDSC and Th17 cells in lymphoma progression. Molecular oncology 15 (1) (2020)